• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Rare cutaneous reactions after ChAdOx1 (Oxford-AstraZeneca) vaccine: 12 case series from Brazil.ChAdOx1（牛津-阿斯利康）疫苗接种后的罕见皮肤反应：来自巴西的12例病例系列报道
J Eur Acad Dermatol Venereol. 2022 Aug;36(8):e601-e603. doi: 10.1111/jdv.18112. Epub 2022 Apr 12.
2
In adults, the Oxford/AstraZeneca vaccine had 70% efficacy against COVID-19 >14 d after the 2nd dose.在成年人中，牛津/阿斯利康疫苗在第 2 剂接种后 14 天以上对 COVID-19 的有效率为 70%。
Ann Intern Med. 2021 Mar;174(3):JC29. doi: 10.7326/ACPJ202103160-029. Epub 2021 Mar 2.
3
Delayed Cutaneous Adverse Reaction of the AstraZeneca COVID-19 Vaccine in a Breastfed Female Infant: A Coincidence or a Rare Effect?阿斯利康新冠疫苗在一名母乳喂养女婴中引起的迟发性皮肤不良反应：巧合还是罕见效应？
Vaccines (Basel). 2022 Apr 13;10(4):602. doi: 10.3390/vaccines10040602.
4
Increment of D-dimer Associated with Immune Thrombotic Thrombocytopenia in ChAdOx1 nCoV-19 Vaccinated Individuals.腺病毒载体新冠疫苗接种者的 D-二聚体升高与免疫性血栓性血小板减少症相关。
Arch Med Res. 2022 Jun;53(4):341-351. doi: 10.1016/j.arcmed.2022.03.008. Epub 2022 May 6.
5
Sweet syndrome after Oxford-AstraZeneca COVID-19 vaccine (AZD1222) in an elderly female.老年女性接种牛津-阿斯利康 COVID-19 疫苗（AZD1222）后出现 Sweet 综合征。
Dermatol Ther. 2021 Nov;34(6):e15146. doi: 10.1111/dth.15146. Epub 2021 Oct 7.
6
Limb ischemia and pulmonary artery thrombosis after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine: a case of vaccine-induced immune thrombotic thrombocytopenia.ChAdOx1 nCoV-19（牛津-阿斯利康）疫苗接种后出现肢体缺血和肺动脉血栓形成：1例疫苗诱导的免疫性血栓性血小板减少症
CMAJ. 2021 Jun 14;193(24):E906-E910. doi: 10.1503/cmaj.210795. Epub 2021 May 14.
7
Thrombotic Adverse Events Reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 Vaccines: Comparison of Occurrence and Clinical Outcomes in the EudraVigilance Database.关于Moderna、辉瑞和牛津-阿斯利康新冠疫苗报告的血栓形成不良事件：欧洲药物警戒数据库中发生率和临床结果的比较
Vaccines (Basel). 2021 Nov 15;9(11):1326. doi: 10.3390/vaccines9111326.
8
Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine.接种ChAdOx1 nCoV-19（牛津-阿斯利康）疫苗后发生的自身免疫性肝炎。
J Hepatol. 2021 Nov;75(5):1249-1250. doi: 10.1016/j.jhep.2021.06.014. Epub 2021 Jun 22.
9
Sustained COVID-19 vaccine willingness after safety concerns over the Oxford-AstraZeneca vaccine.对牛津-阿斯利康疫苗的安全性担忧后，对 COVID-19 疫苗的持续意愿。
Dan Med J. 2021 Mar 31;68(5):A03210292.
10
Self-reported side effects of the Oxford AstraZeneca COVID-19 vaccine among healthcare workers in Ethiopia, Africa: A cross-sectional study.非洲埃塞俄比亚医护人员报告的牛津阿斯利康 COVID-19 疫苗的副作用：一项横断面研究。
Front Public Health. 2022 Jul 19;10:937794. doi: 10.3389/fpubh.2022.937794. eCollection 2022.

引用本文的文献

1
Identification of cross reactive T cell responses in adenovirus based COVID 19 vaccines.基于腺病毒的新冠疫苗中交叉反应性T细胞应答的鉴定
NPJ Vaccines. 2024 Jun 5;9(1):99. doi: 10.1038/s41541-024-00895-z.
2
Pityriasis Rosea and Pityriasis Rosea-like Eruption Following COVID-19 Vaccinations: Case Series from Oman.新型冠状病毒肺炎疫苗接种后玫瑰糠疹及玫瑰糠疹样皮疹：阿曼的病例系列报道
Oman Med J. 2023 Nov 30;38(6):e579. doi: 10.5001/omj.2024.01. eCollection 2023 Nov.

本文引用的文献

1
A case of erythroderma with elevated serum immunoglobulin E and thymus and activation-regulated chemokine levels following coronavirus disease 2019 vaccination.1例新型冠状病毒肺炎疫苗接种后出现血清免疫球蛋白E及胸腺与活化调节趋化因子水平升高的红皮病病例。
J Dermatol. 2022 Mar;49(3):e117-e118. doi: 10.1111/1346-8138.16257. Epub 2021 Nov 25.
2
Cutaneous findings following COVID-19 vaccination: review of world literature and own experience.接种 COVID-19 疫苗后的皮肤表现：世界文献复习和自身经验。
J Eur Acad Dermatol Venereol. 2022 Feb;36(2):172-180. doi: 10.1111/jdv.17744. Epub 2021 Nov 2.
3
Cutaneous adverse reactions after COVID-19 vaccines in a cohort of 2740 Italian subjects: An observational study.在一个由 2740 名意大利受试者组成的队列中观察到 COVID-19 疫苗接种后的皮肤不良反应：一项观察性研究。
Dermatol Ther. 2021 Nov;34(6):e15153. doi: 10.1111/dth.15153. Epub 2021 Oct 13.
4
Generalized bullous fixed drug eruption after Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccination.牛津-阿斯利康（ChAdOx1 nCoV-19）疫苗接种后出现的全身性大疱性固定性药疹。
Clin Exp Dermatol. 2022 Feb;47(2):428-432. doi: 10.1111/ced.14926. Epub 2021 Oct 10.
5
Small-vessel vasculitis following Oxford-AstraZeneca vaccination against SARS-CoV-2.接种牛津-阿斯利康新冠疫苗后发生的小血管血管炎。
J Eur Acad Dermatol Venereol. 2021 Nov;35(11):e741-e743. doi: 10.1111/jdv.17547. Epub 2021 Aug 4.
6
Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases.接种 SARS-CoV-2 疫苗后的皮肤反应：一项对 405 例病例的西班牙全国性横断面研究。
Br J Dermatol. 2022 Jan;186(1):142-152. doi: 10.1111/bjd.20639. Epub 2021 Sep 21.
7
Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases.报告的 Moderna 和辉瑞 COVID-19 疫苗接种后皮肤反应：基于登记的 414 例病例研究。
J Am Acad Dermatol. 2021 Jul;85(1):46-55. doi: 10.1016/j.jaad.2021.03.092. Epub 2021 Apr 7.
8
Lichen planus arising after COVID-19 vaccination.新冠病毒疫苗接种后出现的扁平苔藓。
J Eur Acad Dermatol Venereol. 2021 Jul;35(7):e414-e415. doi: 10.1111/jdv.17221. Epub 2021 Mar 28.
9
Annular lichen planus associated with coronavirus SARS-CoV-2 disease (COVID-19).与冠状病毒SARS-CoV-2疾病（COVID-19）相关的环状扁平苔藓。
Int J Dermatol. 2021 Feb;60(2):246-247. doi: 10.1111/ijd.15338. Epub 2020 Dec 15.

Rare cutaneous reactions after ChAdOx1 (Oxford-AstraZeneca) vaccine: 12 case series from Brazil.

作者信息

Seque C A, Enokihara M M S S, Nascimento M M, Porro A M, Tomimori J

机构信息

Dermatology Department, Federal University of Sao Paulo, Sao Paulo, Brazil.

Programa de Pós graduação em Medicina Translacional, Federal University of São Paulo, Sao Paulo, Brazil.

出版信息

J Eur Acad Dermatol Venereol. 2022 Aug;36(8):e601-e603. doi: 10.1111/jdv.18112. Epub 2022 Apr 12.

DOI:10.1111/jdv.18112
PMID:35349766
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9114916/
Abstract
摘要